|
1
|
De Vita F, Di Martino N, Fabozzi A,
Laterza MM, Ventriglia J, Savastano B, Petrillo A, Gambardella V,
Sforza V, Marano L, et al: Clinical management of advanced gastric
cancer: The role of new molecular drugs. World J Gastroenterol.
20:14537–14558. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cives M, Ciavarella S, Rizzo FM, De Matteo
M, Dammacco F and Silvestris F: Bendamustine overcomes resistance
to melphalan in myeloma cell lines by inducing cell death through
mitotic catastrophe. Cell Signal. 25:1108–1117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao GP, Dai S, Chen RS, Wen HM, Yin L,
Shi LW, Shi XD, Liu WL, Liu XH, Li Y, et al: Dictionary Chinese
materia medica. Dictionary Chinese Materia Medica. Yu HA and Liu
SF: 1. 2nd edition. Shanghai Science and Technology Press;
Shanghai: pp. p10002006
|
|
4
|
Chinese Pharmacopoeia Commission:
Pharmacopoeia of the People's Republic of China. Pharmacopoeia of
the People's Republic of China. Zhao YY: 1. 10th edition. Medicine
Science and Technology Press of China; Beijing: pp. p1092015
|
|
5
|
He ZM, Tong JM and Gong FC: Study on the
analgesic effect of Chelidonium majus L. Chin Tradit Herb Drugs.
34:837–838. 2003.
|
|
6
|
Colombo ML and Bosisio E: Pharmacological
activities of Chelidonium majus L. (Papaveraceae). Pharmacol Res.
33:127–134. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noureini SK and Wink M: Transcriptional
down regulation of hTERT and senescence induction in HepG2 cells by
chelidonine. World J Gastroenterol. 15:3603–3610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paul A, Bishayee K, Ghosh S, Mukherjee A,
Sikdar S, Chakraborty D, Boujedaini N and Khuda-Bukhsh AR:
Chelidonine isolated from ethanolic extract of Chelidonium majus
promotes apoptosis in HeLa cells through p38-p53 and PI3K/AKT
signalling pathways. J Chin Integ Med. 10:1025–1038. 2012.
View Article : Google Scholar
|
|
9
|
Paul A, Das S, Das J, Samadder A and
Khuda-Bukhsh AR: Cytotoxicity and apoptotic signalling cascade
induced by chelidonine-loaded PLGA nanoparticles in HepG2 cells in
vitro and bioavailability of nano-chelidonine in mice in vivo.
Toxicol Lett. 222:10–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park JE, Cuong TD, Hung TM, Lee I, Na M,
Kim JC, Ryoo S, Lee JH, Choi JS, Woo MH and Min BS: Alkaloids from
Chelidonium majus and their inhibitory effects on LPS-induced NO
production in RAW264.7 cells. Bioorg Med Chem Lett. 21:6960–6963.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heinle H, Hagelauer D, Pascht U, Kelber O
and Weiser D: Intestinal spasmolytic effects of STW 5 (Iberogast)
and its components. Phytomedicine. 13(Suppl 5): 75–79. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iagodina OV, Niko'/skaia EB and Faddeeva
MD: Inhibition of liver mitochondrial monoamine oxidase activity by
alkaloids isolated from Chelidonium and Macleaya and by their
derivative drugs. Tsitologiia. 45:1032–1037. 2003.In Russian.
|
|
13
|
Paul A, Das J, Das S, Samadder A and
Khuda-Bukhsh AR: Poly (lactide-co-glycolide) nano-encapsulation of
chelidonine, an active bioingredient of greater celandine
(Chelidonium majus), enhances its ameliorative potential against
cadmium induced oxidative stress and hepatic injury in mice.
Environ Toxicol Pharmacol. 36:937–947. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koriem KM, Arbid MS and Asaad GF:
Chelidonium majus leaves methanol extract and its chelidonine
alkaloid ingredient reduce cadmium-induced nephrotoxicity in rats.
J Nat Med. 67:159–167. 2013. View Article : Google Scholar
|
|
15
|
Staniszewski A, Slesak B, Kołodziej J,
Harłozińska-Szmyrka A and Nowicky JW: Lymphocyte subsets in
patients with lung cancer treated with thiophosphoric acid alkaloid
derivatives from Chelidonium majus L. (Ukrain). Drugs Exp Clin Res.
18(Suppl): 63–67. 1992.PubMed/NCBI
|
|
16
|
Kadan P, Korsh OB and Melnyk A: Ukrain
therapy of recurrent breast cancer with lung metastases (case
report). Drugs Exp Clin Res. 22:243–245. 1996.PubMed/NCBI
|
|
17
|
Uglyanitsa KN, Nechiporenko NA, Nefyodov
LI, Doroshenko YM, Brzosko W and Nowicky W: Results of Ukrain
monotherapy of prostate cancer. Drugs Exp Clin Res. 26:191–193.
2000.
|
|
18
|
Zemskov V, Prokopchuk O, Susak Y, Zemskov
S, Tkachenko O, Hodysh Y and Nowicky W: Efficacy of ukrain in the
treatment of pancreatic cancer. Langenbecks Arch Surg. 387:84–89.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
El-Readi MZ, Eid S, Ashour ML, Tahrani A
and Wink M: Modulation of multidrug resistance in cancer cells by
cheli-donine and Chelidonium majus alkaloids. Phytomedicine.
20:282–294. 2013. View Article : Google Scholar
|
|
20
|
Hammerová J, Uldrijan S, Táborská E and
Slaninová I: Benzo[c] phenanthridine alkaloids exhibit strong
anti-proliferative activity in malignant melanoma cells regardless
of their p53 status. J Dermatol Sci. 62:22–35. 2011.
|
|
21
|
Kaminskyy V, Kulachkovskyy O and Stoika R:
A decisive role of mitochondria in defining rate and intensity of
apoptosis induction by different alkaloids. Toxicol Lett.
177:168–181. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vitale I, Galluzzi L, Castedo M and
Kroemer G: Mitotic catastrophe: A mechanism for avoiding genomic
instability. Nat Rev Mol Cell Biol. 12:385–392. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Caruso R, Fedele F, Lucianò R, Branca G,
Parisi C, Paparo D and Parisi A: Mitotic catastrophe in malignant
epithelial tumors: The pathologis'/s viewpoint. Ultrastruct Pathol.
35:66–71. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lindgren T, Stigbrand T, Johansson L,
Riklund K and Eriksson D: Alterations in gene expression during
radiation-induced mitotic catastrophe in HeLa Hep2 cells.
Anticancer Res. 34:3875–3880. 2014.PubMed/NCBI
|
|
25
|
Grzanka D, Marszałek A, Izdebska M,
Gackowska L, Andrzej Szczepanski M and Grzanka A: Actin
cytoskeleton reorganization correlates with cofilin nuclear
expression and ultrastructural changes in cho aa8 cell line after
apoptosis and mitotic catastrophe induction by doxorubicin.
Ultrastruct Pathol. 35:130–138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Wu E, Wu J, Wang TL, Hsieh HP and
Liu X: An antimitotic and antivascular agent BPR0L075 overcomes
multidrug resistance and induces mitotic catastrophe in
paclitaxel-resistant ovarian cancer cells. PLoS One. 8:e656862013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Magalska A, Sliwinska M, Szczepanowska J,
Salvioli S, Franceschi C and Sikora E: Resistance to apoptosis of
HCW-2 cells can be overcome by curcumin- or vincristine-induced
mitotic catastrophe. Int J Cancer. 119:1811–1818. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mansilla S, Bataller M and Portugal J:
Mitotic catastrophe as a consequence of chemotherapy. Anticancer
Agents Med Chem. 6:589–602. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kemény-Beke A, Aradi J, Damjanovich J,
Beck Z, Facskó A, Berta A and Bodnár A: Apoptotic response of uveal
melanoma cells upon treatment with chelidonine, sanguinarine and
chelerythrine. Cancer Lett. 237:67–75. 2006. View Article : Google Scholar
|
|
30
|
Philchenkov A, Kaminskyy V, Zavelevich M
and Stoika R: Apoptogenic activity of two benzophenanthridine
alkaloids from Chelidonium majus L. does not correlate with their
DNA damaging effects. Toxicol In Vitro. 22:287–295. 2008.
View Article : Google Scholar
|
|
31
|
Panzer A, Joubert AM, Bianchi PC, Hamel E
and Seegers JC: The effects of chelidonine on tubulin
polymerisation, cell cycle progression and selected signal
transmission pathways. Eur J Cell Biol. 80:111–118. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ji YB, Qu ZY and Zou X: Juglone-induced
apoptosis in human gastric cancer SGC-7901 cells via the
mitochondrial pathway. Exp Toxicol Pathol. 63:69–78. 2011.
View Article : Google Scholar
|
|
33
|
Kundu S, Kim TH, Yoon JH, Shin HS, Lee J,
Jung JH and Kim HS: Viriditoxin regulates apoptosis and autophagy
via mitotic catastrophe and microtubule formation in human prostate
cancer cells. Int J Oncol. 45:2331–2340. 2014.PubMed/NCBI
|
|
34
|
Roy RV, Suman S, Das TP, Luevano JE and
Damodaran C: Withaferin A, a steroidal lactone from Withania
somnifera, induces mitotic catastrophe and growth arrest in
prostate cancer cells. J Nat Prod. 76:1909–1915. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
de-Sá-Júnior PL, Pasqualoto KF, Ferreira
AK, Tavares MT, Damião MC, de Azevedo RA, Câmara DA, Pereira A, de
Souza DM and Parise Filho R: RPF101, a new capsaicin-like analogue,
disrupts the microtubule network accompanied by arrest in the G2/M
phase, inducing apoptosis and mitotic catastrophe in the MCF-7
breast cancer cells. Toxicol Appl Pharmacol. 266:385–398. 2013.
View Article : Google Scholar
|
|
36
|
Suematsu T, Li Y, Kojima H, Nakajima K,
Oshimura M and Inoue T: Deacetylation of the mitotic checkpoint
protein BubR1 at lysine 250 by SIRT2 and subsequent effects on
BubR1 degradation during the prometaphase/anaphase transition.
Biochem Biophys Res Commun. 453:588–594. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu H: Regulation of APC-Cdc20 by the
spindle checkpoint. Curr Opin Cell Biol. 14:706–714. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lane SI and Jones KT: Non-canonical
function of spindle assembly checkpoint proteins after APC
activation reduces aneuploidy in mouse oocytes. Nat Commun.
5:34442014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kapanidou M, Lee S and Bolanos-Garcia VM:
BubR1 kinase: Protection against aneuploidy and premature aging.
Trends Mol Med. 21:364–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bolanos-Garcia VM, Nilsson J and Blundell
TL: The architecture of the BubR1 tetratricopeptide tandem repeat
defines a protein motif underlying mitotic checkpoint-kinetochore
communication. Bioarchitecture. 2:23–27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ibrahim B: Systems biology modeling of
five pathways for regulation and potent inhibition of the
anaphase-promoting complex (APC/C): Pivotal roles for MCC and
BubR1. OMICS. 19:294–305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lentini L, Piscitello D, Veneziano L and
Di Leonardo A: Simultaneous reduction of MAD2 and BUBR1 expression
induces mitotic spindle alterations associated with p53 dependent
cell cycle arrest and death. Cell Biol Int. 38:933–941. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Patel D and McCance DJ: Compromised
spindle assembly checkpoint due to altered expression of Ubch10 and
Cdc20 in human papillomavirus type 16 E6- and E7-expressing
keratinocytes. J Virol. 84:10956–10964. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lara-Gonzalez P, Scott MI, Diez M, Sen O
and Taylor SS: BubR1 blocks substrate recruitment to the APC/C in a
KEN-box-dependent manner. J Cell Sci. 124:4332–4345. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Brito DA and Rieder CL: Mitotic checkpoint
slippage in humans occurs via cyclin B destruction in the presence
of an active checkpoint. Curr Biol. 16:1194–1200. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Galán-Malo P, Vela L, Gonzalo O,
Calvo-Sanjuán R, Gracia-Fleta L, Naval J and Marzo I: Cell fate
after mitotic arrest in different tumor cells is determined by the
balance between slippage and apoptotic threshold. Toxicol Appl
Pharmacol. 258:384–393. 2012. View Article : Google Scholar
|
|
47
|
Qi M, Yao G, Fan S, Cheng W, Tashiro S,
Onodera S and Ikejima T: Pseudolaric acid B induces mitotic
catastrophe followed by apoptotic cell death in murine fibrosarcoma
L929 cells. Eur J Pharmacol. 683:16–26. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu WT, Chen C, Lu IC, Kuo SC, Lee KH,
Chen TL, Song TS, Lu YL, Gean PW and Hour MJ: MJ-66 induces
malignant glioma cells G2/M phase arrest and mitotic catastrophe
through regulation of cyclin B1/Cdk1 complex. Neuropharmacology.
86:219–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jin SQ and Zhan QM: Cell cycle checkpoint
and tumour. Molecular Oncology. Liu S: People's Medical Publishing
House; Beijing: pp. p3642005
|
|
50
|
Giovinazzi S, Bellapu D, Morozov VM and
Ishov AM: Targeting mitotic exit with hyperthermia or APC/C
inhibition to increase paclitaxel efficacy. Cell Cycle.
12:2598–2607. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Castedo M, Perfettini JL, Roumier T,
Valent A, Raslova H, Yakushijin K, Horne D, Feunteun J, Lenoir G,
Medema R, et al: Mitotic catastrophe constitutes a special case of
apoptosis whose suppression entails aneuploidy. Oncogene.
23:4362–4370. 2004. View Article : Google Scholar : PubMed/NCBI
|
